Physician profile
Steven Toscano
NPI 1730384850
$1,563.02
in general payments reported to CMS, 2019-2025
9 companies · $61.63 in 2025
The $61.63 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.79 · 2023: $443 · 2024: $1,020 · 2025: $61.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $655.89 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $296.99 | 2023-2024 | Relistor |
| Valinor Pharma, LLC | $199.91 | 2023-2024 | Movantik |
| Collegium Pharmaceutical, INC. | $183.90 | 2021-2024 | Xtampza, Belbuca |
| Ibsa Pharma INC. | $113.32 | 2023-2024 | Tirosint, Licart, Flector |
| Painteq LLC | $45.52 | 2024 | Painteq |
| Boston Scientific Corporation | $27.62 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $27.55 | 2021-2024 | Ajovy |
| Biodelivery Sciences International, INC. | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Toscano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.